Target intelligence / Profile preview

INTS6L antisense RNA 1 (non-protein coding) (INTS6L-AS1)

Target
INTS6L-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

INTS6L antisense RNA 1 (INTS6L-AS1) is a long non-coding RNA (lncRNA) gene, also known as DDX26B-AS1, that produces an RNA transcript but does not encode a protein[3]. As an antisense RNA, it is transcribed from the DNA strand opposite to its neighboring genes (such as INTS6L or DDX26B), and it may have regulatory effects at the RNA level—typically influencing gene expression, chromatin structure, or RNA stability in cis (on neighboring genes) or trans (elsewhere in the genome)[2]. However, for INTS6L-AS1, there is currently no direct evidence supporting its function as a therapeutic target or established disease role. No known drugs interact with this lncRNA, and there is no evidence for its use as a biomarker or any known safety concerns. The molecule is primarily classified as a non-coding regulatory RNA, not as a receptor, enzyme, transporter, or other canonical drug target[3].

Other names
DDX26B-AS1DDX26B antisense RNA 1 (non-protein coding)
02

Mechanism of action

Acts as a long non-coding antisense RNA, potentially modulating gene expression via RNA interaction; exact mechanisms for INTS6L-AS1 not elucidated[2][3]

03

Biological functions

Antisense regulation of gene expressionPotential regulation of chromatin structure or nearby gene expression in cis or trans (general property of antisense lncRNAs)[2]
04

Disease associations

No specific disease associations currently established for INTS6L-AS1, though analogous lncRNAs are widely implicated in cancer and other complex disease regulation[2][3]

Beyond the preview

Go deeper on INTS6L antisense RNA 1 (non-protein coding) (INTS6L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on INTS6L antisense RNA 1 (non-protein coding) (INTS6L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call